ZNTL
Zentalis Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.99
−2.92%Leverage
- Debt / equity
- 0.26x
- Net debt / equity
- 0.09x
- Debt / assets
- 0.18x
- Debt / EBITDA
- -0.22x
- Net debt / EBITDA
- -0.07x
Liquidity & coverage
- Current ratio
- 4.82x
- Quick ratio
- 4.82x
- Cash ratio
- 4.64x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $143.7M
Cash & dividend
- FCF / debt
- -4.27x
- Cash flow / debt
- -4.27x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026